The global diabetes injection pens market is projected to grow at a CAGR of approximately 7% through 2028. Market expansion ...

The launch of an oral semaglutide pill approved for weight loss represents a new frontier for GLP-1 drugs. Katie Rosseinsky ...

WANNABE slimmers were today urged not to suddenly restart fat jabs at the same dose after pressing pause over Christmas.

In the fight against climate change, companies are navigating compounding problems: supply-chain issues, tariffs, changing ...

Wegovy for weight loss is a medical treatment that mimics a natural gut hormone to suppress hunger and support significant, ...

From injectables to pills: how the new Wegovy tablet will change the weight loss market forever - IN FOCUS: The launch of an ...

Eli Lilly hiked its revenue growth guidance by 7%, while Novo Nordisk was forced to slash its targets by ~12%. See why I'm ...

Makers of smartwatches and other wearables have spent years trying to measure blood sugar without pricking your skin. The ...

Drugmaker Cipla has launched Afrezza (insulin human) inhalation powder, the company said, about a year after the product got regulatory approval in India. The company has the exclusive distribution ...

Novo Nordisk’s Wegovy weight loss pill hit U.S. pharmacies this week. Here’s how it works, who qualifies, how to take it, ...

Novo Nordisk has launched the Wegovy pill in the US, offering a 1.5 mg starter dose of semaglutide, expanding its weight-loss ...

MNT speaks with three obesity medicine experts to find out more about the FDA-aproved Wegovy pill and how it's different from the Wegovy injection.